Hamilton Thorne Ltd. (HTLZF)
USD 1.59
(0.01%)
USD 1.59
(0.01%)
| Year | Total Debt | Total Debt Growth |
|---|---|---|
| 2023 | 27.81 Million USD | 55.71% |
| 2022 | 17.86 Million USD | 92.29% |
| 2021 | 9.28 Million USD | -9.61% |
| 2020 | 10.27 Million USD | -13.22% |
| 2019 | 11.84 Million USD | 23.58% |
| 2018 | 9.58 Million USD | -13.28% |
| 2017 | 11.05 Million USD | 54.0% |
| 2016 | 7.17 Million USD | 85.92% |
| 2015 | 3.85 Million USD | -0.13% |
| 2014 | 3.86 Million USD | -0.48% |
| 2013 | 3.88 Million USD | -1.3% |
| 2012 | 3.93 Million USD | -0.4% |
| 2011 | 3.95 Million USD | -37.13% |
| 2010 | 6.28 Million USD | 25.27% |
| 2009 | 5.01 Million USD | 0.0% |
| 2008 | - USD | 0.0% |
| 2007 | - USD | 0.0% |
| Year | Total Debt | Total Debt Growth |
|---|---|---|
| 2024 Q2 | 26.01 Million USD | -3.94% |
| 2024 Q1 | 27.08 Million USD | -2.6% |
| 2023 Q2 | 19.77 Million USD | 11.02% |
| 2023 Q1 | 17.81 Million USD | -0.28% |
| 2023 Q4 | 27.81 Million USD | 25.89% |
| 2023 Q3 | 22.09 Million USD | 11.72% |
| 2023 FY | 27.81 Million USD | 55.71% |
| 2022 FY | 17.86 Million USD | 92.29% |
| 2022 Q2 | 7.43 Million USD | -11.81% |
| 2022 Q3 | 8.89 Million USD | 19.6% |
| 2022 Q4 | 17.86 Million USD | 100.88% |
| 2022 Q1 | 8.43 Million USD | -9.24% |
| 2021 Q3 | 11.37 Million USD | 39.22% |
| 2021 Q2 | 8.17 Million USD | -12.48% |
| 2021 Q1 | 9.33 Million USD | -9.13% |
| 2021 FY | 9.28 Million USD | -9.61% |
| 2021 Q4 | 9.28 Million USD | -18.36% |
| 2020 Q1 | 14.93 Million USD | 26.13% |
| 2020 FY | 10.27 Million USD | -13.22% |
| 2020 Q2 | 12.34 Million USD | -17.38% |
| 2020 Q3 | 11.46 Million USD | -7.12% |
| 2020 Q4 | 10.27 Million USD | -10.34% |
| 2019 Q1 | 11.59 Million USD | 21.0% |
| 2019 Q2 | 10.76 Million USD | -7.18% |
| 2019 Q4 | 11.84 Million USD | -9.49% |
| 2019 FY | 11.84 Million USD | 23.58% |
| 2019 Q3 | 13.08 Million USD | 21.58% |
| 2018 Q1 | 10.79 Million USD | -2.34% |
| 2018 Q4 | 9.58 Million USD | -7.82% |
| 2018 FY | 9.58 Million USD | -13.28% |
| 2018 Q3 | 10.39 Million USD | 1.33% |
| 2018 Q2 | 10.25 Million USD | -4.94% |
| 2017 Q1 | 6.4 Million USD | -10.8% |
| 2017 Q4 | 11.05 Million USD | -3.0% |
| 2017 FY | 11.05 Million USD | 54.0% |
| 2017 Q3 | 11.39 Million USD | -2.37% |
| 2017 Q2 | 11.66 Million USD | 82.3% |
| 2016 Q1 | 3.83 Million USD | -0.57% |
| 2016 FY | 7.17 Million USD | 85.92% |
| 2016 Q4 | 7.17 Million USD | -1.59% |
| 2016 Q2 | 3.86 Million USD | 0.67% |
| 2016 Q3 | 7.29 Million USD | 88.75% |
| 2015 Q1 | 3.83 Million USD | -0.72% |
| 2015 FY | 3.85 Million USD | -0.13% |
| 2015 Q2 | 3.85 Million USD | 0.36% |
| 2015 Q4 | 3.85 Million USD | 0.67% |
| 2015 Q3 | 3.83 Million USD | -0.43% |
| 2014 Q1 | 3.86 Million USD | -0.57% |
| 2014 FY | 3.86 Million USD | -0.48% |
| 2014 Q3 | 3.85 Million USD | -0.35% |
| 2014 Q4 | 3.86 Million USD | 0.2% |
| 2014 Q2 | 3.87 Million USD | 0.24% |
| 2013 Q4 | 3.88 Million USD | 0.49% |
| 2013 FY | 3.88 Million USD | -1.3% |
| 2013 Q1 | 3.9 Million USD | -0.75% |
| 2013 Q2 | 3.9 Million USD | -0.05% |
| 2013 Q3 | 3.86 Million USD | -0.99% |
| 2012 Q3 | 3.92 Million USD | -0.73% |
| 2012 Q4 | 3.93 Million USD | 0.19% |
| 2012 Q2 | 3.95 Million USD | 0.33% |
| 2012 Q1 | 3.94 Million USD | -0.19% |
| 2012 FY | 3.93 Million USD | -0.4% |
| 2011 Q2 | 6.99 Million USD | 1.26% |
| 2011 FY | 3.95 Million USD | -37.13% |
| 2011 Q4 | 3.95 Million USD | 1.34% |
| 2011 Q3 | 3.89 Million USD | -44.26% |
| 2011 Q1 | 6.9 Million USD | 9.92% |
| 2010 Q4 | 6.28 Million USD | 1.8% |
| 2010 Q1 | 5.01 Million USD | -0.11% |
| 2010 FY | 6.28 Million USD | 25.27% |
| 2010 Q3 | 6.17 Million USD | 27.41% |
| 2010 Q2 | 4.84 Million USD | -3.3% |
| 2009 Q3 | 5.54 Million USD | 4.28% |
| 2009 Q2 | 5.32 Million USD | 0.0% |
| 2009 Q1 | - USD | 0.0% |
| 2009 FY | 5.01 Million USD | 0.0% |
| 2009 Q4 | 5.01 Million USD | -9.6% |
| 2008 Q1 | - USD | 0.0% |
| 2008 Q3 | - USD | 0.0% |
| 2008 Q4 | - USD | 0.0% |
| 2008 FY | - USD | 0.0% |
| 2008 Q2 | - USD | 0.0% |
| 2007 Q4 | - USD | 0.0% |
| 2007 Q3 | - USD | 0.0% |
| 2007 FY | - USD | 0.0% |
| 2007 Q2 | - USD | 0.0% |
| Name | Total Debt | Total Debt Difference |
|---|---|---|
| AVITA Medical, Inc. | 449.48 Thousand USD | -6087.296% |
| Manhattan Scientifics, Inc. | 60 Thousand USD | -46251.403% |
| Össur hf. | 467.73 Million USD | 94.054% |
| QHSLab, Inc. | 1.78 Million USD | -1461.046% |
| Wellstar International, Inc. | 51.36 Million USD | 45.858% |
| Össur hf. | 467.73 Million USD | 94.054% |
| CVR Medical Corp. | - USD | -Infinity% |
| Bionovate Technologies Corp | - USD | -Infinity% |
| Escalon Medical Corp. | 524.71 Thousand USD | -5200.14% |
| Aurora Spine Corporation | 2.67 Million USD | -941.386% |
| BrainsWay Ltd. | 471 Thousand USD | -5804.637% |
| Lattice Biologics Ltd. | - USD | -Infinity% |
| BioElectronics Corporation | 14.83 Million USD | -87.515% |
| Vivos Inc. | - USD | -Infinity% |
| Kelyniam Global, Inc. | 496.39 Thousand USD | -5502.518% |
| REMSleep Holdings, Inc. | 178.11 Thousand USD | -15514.069% |
| Zecotek Photonics Inc. | 3.22 Million USD | -763.193% |
| Avitar, Inc. | 5.26 Million USD | -428.198% |
| Nanomix Corporation | 11.4 Million USD | -143.821% |
| EKF Diagnostics Holdings plc | 5.21 Million USD | -432.976% |
| Theraclion SA | 1.95 Million EUR | -1325.659% |
| Lifeline Biotechnologies, Inc. | - USD | -Infinity% |
| Positron Corporation | 1.78 Million USD | -1455.823% |
| Rafina Innovations Inc. | - USD | -Infinity% |
| Electromedical Technologies, Inc. | 1.69 Million USD | -1537.332% |
| Lombard Medical, Inc. | 32.29 Million USD | 13.877% |
| ALR Technologies Inc. | 19.26 Million USD | -44.366% |
| Stratec SE | 156.16 Million USD | 82.191% |
| Vycor Medical, Inc. | 1.11 Million USD | -2404.922% |
| Heart Tronics, Inc. | 209.28 Thousand USD | -13188.502% |
| MicroPort Scientific Corporation | 1.69 Billion USD | 98.362% |
| VMS Rehab Systems, Inc. | 133.52 USD | -20828870.941% |
| NewCardio, Inc. | 3 Million USD | -827.028% |
| Guided Therapeutics, Inc. | 2.05 Million USD | -1251.354% |
| Ingen Technologies, Inc. | 631.15 Thousand USD | -4306.327% |
| Odyssey Group International, Inc. | 2.14 Million USD | -1196.748% |
| CYduct Diagnostics, Inc. | 670 Thousand USD | -4050.872% |
| Wellness Center USA, Inc. | 4.04 Million USD | -588.049% |
| SANUWAVE Health, Inc. | 31.94 Million USD | 12.939% |
| IR-Med Inc. | 161 Thousand USD | -17173.815% |
| Perimeter Medical Imaging AI, Inc. | 192.89 Thousand USD | -14317.681% |
| Polarean Imaging plc | 216.38 Thousand USD | -12752.481% |
| United American Healthcare Corporation | - USD | -Infinity% |
| ECGI Holdings, Inc. | 3.17 Million USD | -776.966% |
| Nu-Med Plus, Inc. | 100 Thousand USD | -27710.842% |
| Capital Group Holdings, Inc. | 4944.00 USD | -562417.031% |
| ADM Tronics Unlimited, Inc. | 799.65 Thousand USD | -3377.838% |
| Medical Supply International USA, Inc. | 227 Thousand USD | -12151.364% |
| Urologix, Inc. | 5.33 Million USD | -421.486% |
| Rapid Therapeutic Science Laboratories, Inc. | 3.83 Million USD | -626.003% |
| Nexeon MedSystems Inc. | 4.21 Million USD | -559.774% |
| SS Innovations International, Inc. | 8.21 Million USD | -238.4% |
| Qualis Innovations, Inc. | 9102.00 USD | -305446.495% |
| Smith & Nephew plc | 3.07 Billion USD | 99.097% |
| NIOX Group Plc | 1.4 Million USD | -1886.063% |
| Fuse Medical, Inc. | 1.99 Million USD | -1294.963% |
| Broncus Holding Corporation | 2.35 Million USD | -1081.248% |
| Brain Scientific Inc. | 2.86 Million USD | -871.224% |
| Pressure BioSciences, Inc. | 22.75 Million USD | -22.201% |
| Health Logic Interactive Inc. | 40.44 Thousand USD | -68667.227% |